These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16099651)

  • 1. Synthesis of some pyrazole derivatives and preliminary investigation of their affinity binding to P-glycoprotein.
    Manna F; Chimenti F; Fioravanti R; Bolasco A; Secci D; Chimenti P; Ferlini C; Scambia G
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4632-5. PubMed ID: 16099651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halogenated chalcones with high-affinity binding to P-glycoprotein: potential modulators of multidrug resistance.
    Bois F; Beney C; Boumendjel A; Mariotte AM; Conseil G; Di Pietro A
    J Med Chem; 1998 Oct; 41(21):4161-4. PubMed ID: 9767651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of pyrazole-based hybrid molecules: search for potent multidrug resistance modulators.
    Singh P; Paul K; Holzer W
    Bioorg Med Chem; 2006 Jul; 14(14):5061-71. PubMed ID: 16554161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted 4-acylpyrazoles and 4-acylpyrazolones: synthesis and multidrug resistance-modulating activity.
    Chiba P; Holzer W; Landau M; Bechmann G; Lorenz K; Plagens B; Hitzler M; Richter E; Ecker G
    J Med Chem; 1998 Oct; 41(21):4001-11. PubMed ID: 9767638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of some imidazolyl-thioacetyl-pyrazolinone derivatives and their antinociceptive and anticancer activities.
    Demirayak S; Kayagil I; Yurttas L; Aslan R
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):74-9. PubMed ID: 20030511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, cytotoxicity, antitumor activity and sequence selective binding of two pyrazole analogs structurally related to the antitumor agents U-71,184 and adozelesin.
    Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Gambari R; Bianchi N; Passadore M; Ambrosino P; Mongelli N; Cozzi P; Geroni C
    Anticancer Drug Des; 1997 Oct; 12(7):555-76. PubMed ID: 9365502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of progesterone-adenine hybrids as bivalent inhibitors of P-glycoprotein-mediated multidrug efflux.
    Zeinyeh W; Alameh G; Radix S; Grenot C; Dumontet C; Walchshofer N
    Bioorg Med Chem Lett; 2010 May; 20(10):3165-8. PubMed ID: 20399647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysubstituted pyrazoles. Part 2: Sulphonamidophenylhydrazone-2-pyrazolin-4-ones and sulphonamidophenylazopyrazoles as potential anticancer agents.
    Soliman FS; Shafik RM
    Pharmazie; 1975 Jul; 30(7):436-9. PubMed ID: 1178757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide binding to the multidrug resistance P-glycoprotein as studied by ESR spectroscopy.
    Delannoy S; Urbatsch IL; Tombline G; Senior AE; Vogel PD
    Biochemistry; 2005 Oct; 44(42):14010-9. PubMed ID: 16229490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of 1,4-dihydrobenzothiopyrano[4,3-c]pyrazole derivatives, novel pro-apoptotic mitochondrial targeted agents.
    Dalla Via L; Marini AM; Salerno S; La Motta C; Condello M; Arancia G; Agostinelli E; Toninello A
    Bioorg Med Chem; 2009 Jan; 17(1):326-36. PubMed ID: 19022678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiandrogenic activity of some new 3-substituted androstano[17,16-c]-5'-aryl-pyrazoline and their derivatives.
    Amr Ael-G; Abdel-Latif NA; Abdalla MM
    Bioorg Med Chem; 2006 Jan; 14(2):373-84. PubMed ID: 16182532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antimicrobial activity of some 1-(2,4-dinitrophenyl)-3-(3-nitrophenyl)-5-(4-substituted phenyl)-4-bromo-2-pyrazolines and 1-(2,4-dinitrophenyl)-3-(3-nitrophenyl)-5-(4-substituted phenyl)-2-pyrazolin-4-ones.
    Mishra SK; Sahoo S; Panda PK; Mishra SR; Mohanta RK; Ellaiah P; Panda CS
    Acta Pol Pharm; 2007; 64(4):359-64. PubMed ID: 18536162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
    Gopinath VS; Thimmaiah P; Thimmaiah KN
    Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
    Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
    Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization and fluorescence studies of 3,5-diaryl substituted 2-pyrazolines.
    Joshi nee Pant G; Singh P; Rawat BS; Rawat MS; Joshi GC
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Mar; 78(3):1075-9. PubMed ID: 21233011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological activity of new strobilurin derivatives with a 1H-pyrazol-5-oxy side chain.
    Li M; Liu CL; Yang JC; Li L; Li ZN; Zhang H; Li ZM
    Nat Prod Commun; 2009 Sep; 4(9):1215-20. PubMed ID: 19831032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake.
    Ang WH; Pilet S; Scopelliti R; Bussy F; Juillerat-Jeanneret L; Dyson PJ
    J Med Chem; 2005 Dec; 48(25):8060-9. PubMed ID: 16335930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel pyrazole carboxamide derivatives and discovery of modulators for apoptosis or autophagy in A549 lung cancer cells.
    Ding XL; Zhang HY; Qi L; Zhao BX; Lian S; Lv HS; Miao JY
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5325-8. PubMed ID: 19683442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
    Huang L; Wang C; Zheng W; Liu R; Yang J; Tang C
    Anticancer Drugs; 2007 Oct; 18(9):1075-80. PubMed ID: 17704658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.